Personal Accident and Health Insurance in Belgium, Key Trends and Opportunities to 2016

The report provides in depth market analysis, information and insights into the Belgian personal accident and health insurance market, including:

• The Belgian personal accident and health insurance market’s growth prospects by personal accident and health insurance categories
• The various distribution channels in the Belgian personal accident and health insurance market
• The competitive landscape in the personal accident and health insurance market
• A description of the personal accident and health reinsurance market in Belgium

In terms of gross written premium, the Belgian personal accident and health insurance segment recorded a positive growth rate during the review period. This growth was primarily due to increases in overall medical expenditure and Belgian outbound tourism. The expansion of the segment was also supported by positive demographic factors such as increased life expectancy and the country’s large urban population. Despite Belgium’s strong statutory healthcare scheme and difficult business conditions, the country’s personal accident and health segment is expected to continue to grow positively over the forecast period.

Buy your copy of this report @ http://www.reportsnreports.com/reports/190944-personal-accident-and-health-insurance-in-belgium-key-trends-and-opportunities-to-2016.html

Report Details:
Published: August 2012
No. of Pages: 208
Price:Single User License:US$1950 Corporate User License:US$3900



Scope
This report provides a comprehensive analysis of the personal accident and health insurance market in Belgium:

• It provides historical values for the Belgian personal accident and health insurance market for the review period (2007–2011) and forecast period (2012–2016)
• It offers a detailed analysis of the key sub-segments in the Belgian personal accident and health insurance market, along with market forecasts until 2016
• It covers an exhaustive list of parameters, including written premium, incurred loss, loss ratio, commissions and expenses, combined ratio, frauds and crimes, total assets, total investment income and retentions
• It analyses the various distribution channels for personal accident and health insurance products in Belgium
• Using Porter’s industry-standard “Five Forces” analysis, it details the competitive landscape in Belgian for the personal accident and health insurance business
• It provides a detailed analysis of the reinsurance market in Belgium and its growth prospects
• It profiles the top personal accident and health insurance companies in Belgium and outlines the key regulations affecting them

Key highlights

• The number of outbound tourists from Belgium increased from 8.4 million in 2007 to 10.5 million in 2011, and is expected to reach 12.7 million by 2016. This significant increase in outbound tourism was the key growth driver of the travel insurance category during the review period.
• In Belgium, all public, private and self-employed individuals are protected under a public social security system, under which health insurance is included. Under this system, public and private employees contribute some proportion of their incomes to a public welfare health insurance fund named mutuelle/mutualité or ziekenfonds/mutualiteit in order to access the country’s public healthcare facilities.
• The Belgian government encourages foreign investment through incentives such as a lower corporate tax structure, national interest deductions, patent income relief, and VAT grouping. In addition, the country’s policy makers offer a variety of fiscal measures designed to facilitate investment.
• In addition, the Belgian insurance industry’s high exposure to government bonds could cause losses for insurance companies over the forecast period, while the increasing losses from frauds and crimes may negatively impact bottom lines and reduce investor confidence.
• During the review period, Belgium’s unfavorable business and economic conditions forced the country’s personal accident and health insurance companies to increase their use of channels with lower marketing and administrative costs.
• A number of multinational insurers, such as AXA, Ergo and Allianz, have significant operations in Belgium and multinationals collectively dominate the country’s personal accident and health insurance segment. Moreover, the Belgian government‘s encouragement of FDI, through liberal regulations, tax reductions, and other fiscal measures, is expected to attract new businesses over the forecast period.

Reasons to buy

• Make strategic business decisions using in depth historic and forecast market data related to the Belgian personal accident and health insurance market and each sector within it
• Understand the demand-side dynamics, key market trends and growth opportunities within the Belgian personal accident and health insurance market
• Assess the competitive dynamics in the personal accident and health insurance market, along with the reinsurance segment
• Identify the growth opportunities and market dynamics within key product categories
• Gain insights into key regulations governing the Belgian insurance market and its impact on companies and the market's future

Non-Life Insurance in Egypt, Key Trends and Opportunities to 2016

The report provides in depth market analysis, information and insights into the Egyptian non-life insurance market, including:

• The Egyptian non-life insurance market’s growth prospects by non-life insurance categories
• The various distribution channels in the Egyptian non-life insurance market
• The competitive landscape in the non-life insurance market in Egypt
• A description of the non-life reinsurance market in Egypt

The Egyptian non-life insurance segment was largely influenced by increases in GDP, automobile sales and the commercial construction industry. Motor insurance accounted for the largest market share of the Egyptian non-life insurance segment during the review period, in terms of gross written premium, followed by property insurance in 2011. Motor insurance is expected to lead the Egyptian non-life insurance segment over the forecast period. The rise in the number of road accidents increased consumer awareness of motor hull and motor third-party liability insurance.

Get your copy of this report @ http://www.reportsnreports.com/reports/190945-non-life-insurance-in-egypt-key-trends-and-opportunities-to-2016.html

Report Details:
Published: August 2012
No. of Pages: 250
Price:Single User License:US$1950 Corporate User License:US$3900


Scope
This report provides a comprehensive analysis of the non-life insurance market in Egypt:

• It provides historical values for the Egyptian non-life insurance market for the report’s 2007–2011 review period and forecast figures for the 2012–2016 forecast period
• It offers a detailed analysis of the key sub-segments in the Egyptian non-life insurance market, along with market forecasts until 2016
• It covers an exhaustive list of parameters, including written premium, incurred loss, loss ratio, commissions and expenses, combined ratio, frauds and crimes, total assets, total investment income and retentions
• It analyses the various distribution channels for non-life insurance products in Egypt
• Using Porter’s industry-standard “Five Forces” analysis, it details the competitive landscape in Egypt for the non-life insurance business
• It provides a detailed analysis of the reinsurance market in Egypt and its growth prospects
• It profiles the top non-life insurance companies in Egypt and outlines the key regulations affecting them

Key highlights

• The growth in Egyptian GDP, which is expected to increase further over the forecast period in the presence of liberalization, is expected to drive the growth of the non-life insurance segment.
• The rise in number of road accidents is expected to encourage growth of the Egyptian non-life insurance segment over the forecast period. The large share of motor insurance is expected to play a major role in the growth of the Egyptian non-life insurance segment over the forecast period.
• Growth in the middle class population, which constituted 31% of the overall population in 2011, and increased risk awareness among consumers regarding the benefits of non-life insurance, are factors expected to drive growth in the segment over the forecast period, as well as the presence of mandatory motor third-party liability insurance.
• Flexibility in regulations, an insurance industry with low penetration and the implementation of privatization and liberalization policies encouraged foreign insurance brokers and agencies to enter the industry during the review period, resulting in an overall increase in the number of brokers and insurance agents.
• Out of all of the distribution channels, insurance brokers are expected to continue their dominance of the Egyptian non-life insurance segment over the forecast period.
• The Egyptian non-life insurance segment comprises both domestic and foreign insurers. As of 2010, there were 20 non-life insurance companies authorized to pursue non-life insurance business in Egypt under the supervision of EFSA.

Reasons to buy

• Make strategic business decisions using in depth historic and forecast market data related to the Egyptian non-life insurance market and each sector within it
• Understand the demand-side dynamics, key market trends and growth opportunities within the Egyptian non-life insurance market
• Assess the competitive dynamics in the non-life insurance market, along with the reinsurance segment
• Identify the growth opportunities and market dynamics within key product categories
• Gain insights into key regulations governing the Egyptian insurance market and its impact on companies and the market's future

Global SOA Governance Market 2011-2015

TechNavio's analysts forecast the Global Service Oriented Architecture (SOA) Governance market to grow at a CAGR of 10.35 percent over the period 2011-2015. One of the key factors contributing to this market growth is the automation of SOA governance. The Global SOA Governance market has also been witnessing a rise in cloud governance. But the general lack of awareness and understanding of SOA governance could pose a challenge to the growth of this market.

TechNavio's report, the Global SOA Governance Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, the EMEA and APAC regions; it also covers the Global SOA Governance market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include IBM Corp., Oracle Corp., Software AG, SOA Software Inc., TIBCO Software Inc.

Other vendors mentioned in the report: Progress Software Corp., Layer 7 Technologies Inc., HP Co., Vordel Ltd., Crosscheck Networks Inc., Managed Methods Inc., and Intel Corp.

Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?

Get your copy of this report @ http://www.reportsnreports.com/reports/190938-global-soa-governance-market-2011-2015.html

Report Details:
Published: September 2012
No. of Pages: 45
Price:Single User License:US$1500 Corporate User License:US$2500

ReportsnReports - Rethinking Male and Female Health and Beauty Routines

This report offers a completely fresh look at men''s and women''s Health and Beauty routines, allowing marketers to understand people''s consumption patterns like never before. This offers unique opportunities to effectively target new consumer groups, behaviors and trends.

Introduction and Landscape
Why was the report written?
A lack of data on actual usage by specific consumers has forced observers to focus on shopper and retail audit data of Health and Beauty products, which provides an incomplete picture. Canadean''s consumer survey provides unique empirical data on actual consumer behavior, providing a completely fresh insight into these markets, consumption patterns and trends.

What is the current market landscape and what is changing?
Traditional differences between men''s and women''s Health and Beauty routines are breaking down, with men increasingly adopting “female” habits. This creates in itself new opportunities for marketers. Meanwhile, the adoption of western consumption patterns by women in BRIC is leading to a greater global convergence of trends amongst women. Brands in the market must position themselves carefully if they are to take advantage of this evolution in men''s and women''s Health and Beauty routines.

What are the key drivers behind recent market changes?
Consumer''s habits and routines are evolving, changing the nature of consumption over time. One of the main drivers of this is the development of BRIC economies, creating a more affluent consumer in this region with different needs to consumers in Western countries. Another key driver is an increased fear of aging, which is leading consumers to take an increased interest in products which target their age-related needs.

What makes this report unique and essential to read?
The analysis provided is unique in the market as it tracks men''s and women''s behavior through to its actual impact on a product market. This provides readers with a unique analysis of the market, driven by survey-based data on consumer trends and groups, which is integrated with market data. This allows marketing tactics and strategy to be updated in line with the very latest consumer behaviors.

Key Features and Benefits
Unique survey data, composed of over 30,000 responses, provides detailed insight of end-consumers behaviors.

Supported by market data, the survey provides market sizing consumption by key consumer groups, both by age and by gender.

Concise case studies identify best practice on how to align marketing practices to effectively target trends.

Trends are sized by volume and value, showing the actual market impact of consumers'' behavior.

Get your copy of this report @ http://www.reportsnreports.com/reports/191349-rethinking-male-and-female-health-and-beauty-routines.html

Report Details:
Published: September 2012
No. of Pages: 66
Price:Single User License:US$2950 Corporate User License:US$8850


Key Market Issues
Many in the industry, especially in Western markets, expected a surge in the consumption of male branded products in the past few years, but growth has been more steady than spectacular. This is partly a result of men already using more grooming products than was realized and partly as a result of ineffective targeting of men by age groups and country.

Men seek out age-specific solutions more often than women. However, effective targeting of age-related needs can be difficult: people are interested in these benefits, but targeting needs created by age requires carefully thought out approaches or advertising risks alienating these consumers.

Growth in the BRIC region will be driven by females adopting Western-style consumption patterns. This is creating a global female consumer, which makes it easier to manage a global brand for women.

However, in Female Personal Hygiene, products should be positioned differently between the BRIC and Non-BRIC regions. Hygiene is a significant issue in BRIC, as shown by the success of Dettol in India, where the brand has extended its sanitation credentials to develop a successful Personal Care range. In contrast, health is less of an issue for consumers in the Non-BRIC region, who look for comfort and indulgence in their Personal Hygiene products.

Women are comfortable using men''s products to meet needs which aren''t being met by products targeted at them. For instance, women will use men''s disposable razors blades if they perceive them to be more effective or better value for money. Equally, they will use a Male Fragrance if they prefer its scent.

Key Highlights
Men are becoming more image-conscious. However, given that men already account for 47% of the volume of Health and Beauty products used in 2011, this increased image-consciousness will result in an increase in men''s consumption frequency rather than increasing product penetration, requiring different marketing tactics to exploit new opportunities.

Men''s consumption in BRIC and Non-BRIC countries is driven by different trends. For instance, men in the BRIC region are more interested in a product''s ingredients: the Quality Seeking and Technology Uptake trends rank six places higher, out of a total of 20 trends, than in the Non-BRIC region.

Whilst taking advantage of the growing number of opportunities in the male grooming market, the industry should not forget that women are still the most likely to use a product that is specially designed for them.

In 5 out of 7 markets the Older women''s share of consumption is equal to or higher than their share of the population. However, they under-consume (compared to their population share) in Haircare and Skincare. While older women tend to have shorter hair and therefore use fewer Haircare products, under-consumption in Skincare points to unmet demand.

Trend analysis shows relatively few women opt for products to meet needs for having the latest formulation, or being socially responsible. Ethical and technological positions can still be important in ensuring consumers think positively about a company, but specific products themselves will have to target other trends in order to have mass appeal.

Global Managed Print Service Market 2011-2015

This report concerns lithium-based rechargeable batteries. Predominantly, they are lithium-ion but we also cover alternatives usually with no intercalation and using lithium metal. All serious analysts predict that these will be responsible for the majority of expenditure on rechargeable batteries over the coming decade, notably in the lithium-ion form. It is therefore important for those making, designing in and using such batteries to understand the variations emerging and their potential for success or failure. Unfortunately, even comprehensive listings of manufacturers and intending manufacturers are hard to find. This report clarifies the situation, revealing the product chemistry, strategy and electric vehicle success of manufacturers and intending manufacturers.

The lithium-ion "Li-ion" battery business (most of the batteries covered in this report) is growing very rapidly to many tens of billions of dollars yearly, thanks to billions of dollars continuing to be invested in the industry. Their use is widening well beyond e-readers, tablets, laptops and mobile phones with vehicles being particularly important for the future, mainly hybrid electric and pure electric vehicles by land, water and air. However, everything about Li-ion is changing, including all electrode and electrolyte chemistry and morphology, so keeping up with the what, why and when is essential. Many niche and volume opportunities are opening up for all in the value chain.

Rechargeable batteries are replacing single-use batteries. Think of what has happened with cameras. They are essential in newly successful products such as hybrid buses, Mars landers, automatic underwater vehicles and silent electric aircraft. Demand has entered the fast growth phase.

For the first time, we analyse 138 manufacturers and putative manufacturers across the world concentrating on the chemistry and format of their batteries, EV sales success (where that is a chosen focus) and strategy in a detailed table, with separate explanation and easy-to-understand pie charts of analysis. Lucid, easily read text gives problems, opportunities and view of the future globally.

Analyst access from IDTechEx

All report purchases include includes up to 30 minutes telephone time with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This needs to be used within three months of purchasing the report.

Get your copy of this report @ http://www.reportsnreports.com/reports/190933-138-lithium-based-rechargeable-battery-manufacturers.html

Report Details:
Published: September 2012
No. of Pages: 50
Price:US$2500   

The Subscriber Data Management (SDM) Market: 2012 - 2016

Subscriber data is a principal asset held by network carriers. Subscriber Data Management (SDM) allows carriers to consolidate and manage their cross domain subscriber data encompassing access preferences, authentication, services, identities, location, and presence into unified data repositories.

Besides enabling considerable OPEX reductions and allowing carriers to deliver more personalised services, thereby reducing churn, SDM can effectively transform carriers into brokers of subscriber identity, both for their own services and for third parties such as content providers, mobile advertisers or retailers.

As Carriers worldwide devise emergent strategies on network modernization including LTE (Long Term Evolution), Fixed Mobile Convergence (FMC) and IMS (IP Multimedia Subsystem) investments, SDM is rapidly gaining popularity. The SDM software and services market is expected to grow at a CAGR of nearly 30 % from 2011 through 2016, eventually accounting for nearly 2 Billion USD in revenue.

Get your copy of this report @ http://www.reportsnreports.com/reports/190940-the-subscriber-data-management-sdm-market-2012-2016.html

Report Details:
Published: August 2012
Price:Single User license:US$2500 Corporate User License:US$3500



The report presents an in depth assessment of the next generation SDM solutions market. Besides analyzing the business case, vendor strategies and the technology behind SDM, the report also presents revenue forecasts for the SDM market from 2012 till 2016 at a regional as a well as global scale.

The report covers the following topics
SDM Technology Overview
The SDM Business Case: Market Drivers, Benefits, Obstacles and Risks
SDM Market Dynamics
SDM Market Analysis and Forecasts
SDM Vendor Assessment
SDM SWOT Analysis, Recommendations and Conclusion.

Key Questions Answered:

The report answers to the following key questions.
What are the strengths and weaknesses of the SDM solutions available on the market?
What are the internal and external driving factors for the growth of the SDM market in the next five years?
Who are the vendors for SDM solutions?
What new features and functionalities are vendors offering to enhance SDM capabilities?
What is the worth of SDM market in 2012 and how the market and players will evolve in the next five years?
How will SDM help operators optimize their investments in LTE and IMS networks?
How will SDM help operators in bundling services and becoming truly convergent service providers?
What is the optimal time period for operators to invest in SDM solutions?
What is the global outlook for SDM solutions?
What is the regional outlook for SDM adoption?

Companies Mentioned:
Accenture
AIS
Alcatel Lucent
Amdocs
Apertio
AT&T
Autonomy
Bharti Airtel
Blueslice
Bridgewater
BroadHop
BSNL
BT
Cell C
CellCo
Digitel
Ericsson
Golden Telecom, Russia
HCPT
HP
Huawei
IBM
MobiFone
Movistar
NSN
NTT DoCoMo
Openet Telecoms Inc.
Oracle Corp.
Orange
Procera
Redknee
Reliance Telecom
Safaricom
Sprint
StarHub
Tekelec
Tele2
Telefonica, Mexico
Telenor
Telkomsel
Telstra
TIM
Time Warenr Cable
T-mobile, UK
T-Mobile, USA
TSTT
Turkcell
Unbound ID
Verizon
Verizon Wireless
Vertica
VimpelCom
Vodafone
Zain
ZTE

Paints and Coatings, U.S. Market 2nd Edition

The U.S. paints and coatings market includes a wide range of solvent-based and water-based formulas, as well as powder coatings. These coating mixtures are specifically suited for a wide range of applications and include: architectural paints and coatings used in the building, maintenance and remodeling of residential and non-residential buildings; automobile paints and coatings applied in the original manufacture and in the repair and maintenance processes; specialty paints and coatings used in the marine, aerospace, roads and bridges industries; industrial paints and coatings that help to protect and identify large machinery, equipment parts, coils and sheets; and paints and coverings used in original equipment manufacturing, such as furniture, appliances and packaging finishes.

SBI estimates the U.S. paints and coatings market in 2011 to be valued at $22.1 billion. Although growth from 2007 to 2011 was less than exciting, it is expected the market will benefit from the reviving U.S. economy, as well as a number of other factors, and will near $30 billion in 2021.

Many factors are paving the way for the U.S. paints and coatings market. As the number of construction projects increases, consumers resume their spending and as the demand for industrial production is raised, the paints and coatings market will benefit. At the same time, there are a number of factors inhibiting market growth, such as more stringent environmental regulations and higher prices of base ingredients. While some of these factors may not affect the paints and coatings market as a whole, specific segments of the market may be influenced.

Get your copy of this report @ http://www.reportsnreports.com/reports/190927-paints-and-coatings-us-market-2nd-edition.html

Report Details:
Published: August 2012
No. of Pages: 125
Price:Single User License:US$4950         Corporate User License:US$7500

http://www.reportsnreports.com/contacts/RequestSample.aspx?name=190927

In 2011, solvent-based paints and coatings are calculated to have claimed nearly 80% of the paints and coatings market. In 2021 it is projected this segment will have lost some share to water-based paints, as Americans seek ways to reduce air pollutants and look out for their own health.

A push to go green has inspired a whole new breed of paints and coatings. Emerging environmentally friendly products include everything from VOC-free and allergy sensitive interior house paints to self-repairing automobile paints and exterior architectural paints that reflect sunlight. This greening trend will likely continue for some time, especially since these friendlier coatings often help to save money as well.

The U.S. Market for Paints and Coatings contains comprehensive historical data (2007-2011) and forecast data (2012-2021) for the paints and coatings market, including the industry’s sub-segments divided by application and type. This report identifies key trends and factors (such as the regulatory scene, new technologies, employment opportunities and economic drivers and challenges), which affect the size and direction of market growth in the United States. Profiles of more than 15 major – or particularly interesting – companies involved in the industry are also included in this report.

Report Methodology

The information contained in The U.S. Market for Paints and Coatings has been gathered from trade associations; business, science and law journals; company literature and websites; interviews with at least ten key individuals, research services and institutes around the world; and is based on data from government agencies, trade associations and other industry sources.

How You Will Benefit From This Report

The U.S. Market for Paints and Coatings details significant trends, schemes and market numbers for a clear overview of the evolving world of paints and coatings in the United States.

This report will help:
Managers identify market opportunities and develop new designs for their paint and coating products.
Research and development professionals stay on top of competitor initiatives and understand the developments and obstacles within the U.S. paints and coatings market.
Business development executives work within the dynamics of the market and identify possible partnerships.
Information and research center librarians access vital information.
Policy makers and government officials understand the dynamics and scope of the market they may be affecting.
Advertising agencies working with clients involved in the paints and coatings market to help design appropriate messages and images.
Investors and stakeholders gain a well-rounded view of the paints and coatings market, including its strengths, weaknesses and likely future direction.

Consumer Payments in the U.S.: The Latino Market

Latino consumers are a bright spot in an otherwise dreary picture for issuers of credit cards. According to Experian Simmons National Consumer Study (NCS) data, between 2004 and 2011 the total number of American consumers with credit cards dropped 5%, while the number of non-Latinos with credit cards fell 7%. During this same period, however, the number of Latino cardholders increased 23%. Thus, the vibrant growth in the number of Latino cardholders helped arrest what would have been an even more significant decline in the total number of American consumers owning credit cards.

Packaged Facts Consumer Payments in the U.S.: The Latino Market illustrates the importance of Latinos to the debit and prepaid card worlds as well. Between 2004 and 2011 the number of Latinos with debit/ATM cards more than doubled (115%), while the number of non-Latinos with debit/ATM cards increased only 51%. Thus the report demonstrates the increasingly crucial role played by Latinos in all aspects of the consumer payments market.

Get your copy of this report @ http://www.reportsnreports.com/reports/190921-consumer-payments-in-the-us-the-latino-market.html

Report Details:
Published: August 2012
No. of Pages: 124
Price:Single User License:US$3995          Corporate User License:US$7990



Overview of the Report

The report begins with an analysis of the top trends driving the Latino consumer payments market and shows how Latinos have sparked growth within the credit and debit card industries. It continues with an overview of Latino consumer payment patterns that includes analyses of how Latinos pay their bills and pay for purchases. The report continues with a chapter examining trends in Latino consumer spending patterns. The next chapter explores the use of credit cards by Latinos and includes an overview of the demographic characteristics of Latino cardholders by type of credit card as well as a review of the personal financial management attitudes of Latinos with credit cards. The following chapter investigates the use of debit cards and prepaid (not gift) cards by Latinos. The final chapter of the report analyzes the impact of media acculturation on Latino consumer payment practices and highlights regional differences in the Latino consumer payments market.

Scope of the Market

This Packaged Facts report focuses on ownership and use by Latinos of credit cards, debit/ATM cards and prepaid debit (not gift) cards and their payment patterns for bills and purchases.

Methodology

The principal source of primary data is the Winter 2012 Experian Simmons NCS, which was fielded between February 2011 and March 2012. Trend data contained in the report is constructed from the Fall 2004 through Fall 2011 Experian Simmons National Consumer Studies. These studies were fielded during the 12-month period ending in December of each year.

Experian Simmons conducts telephone and booklet-based surveys of a large and random sample of consumers who in aggregate represent a statistically accurate cross-section of the U.S. population. Each Experian Simmons NCS surveyrelease involves a sample of approximately 25,000 respondents.

The report is also based upon data collected from a wide range of industry sources, including company websites, trade publications, business newspapers and magazines, consumer blogs and other releases from public companies.

Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional Pipeline Analysis to 2016

There are an estimated 724 projects in development from the top 50 pharmaceutical companies. Together, they have the potential to add billions in value to the current pharmaceutical market in the next five years. What types of drugs are companies developing and what will be the impact of these products on the marketplace and key competitors? In this report, Kalorama Information has analyzed the late-stage R&D pipeline of the 50 top companies in pharmaceuticals -- the companies that produce the lion's share of industry revenues.

Buy your copy of this report @ http://www.reportsnreports.com/reports/190914-pharmaceutical-products-of-the-future-50-company-biopharma-and-traditional-pipeline-analysis-to-2016.html

Report Details:
Published: August 2012
No. of Pages: 220
Price:Single User License:US$2500 Corporate User License:US$5000



Coverage of the 50 Leading Companies


This report takes a look at the pipeline of the following companies. The top companies include pharmaceutical companies that are considered to be the top 50 companies worldwide in terms of generated revenues, these include:
Abbott Laboratories
Actelion
Allergan
Amgen
Astellas
AstraZeneca
Baxter International
Bayer
Biogen IDEC
Boehringer Ingelheim
Bristol-Myers Squibb
Celgene Corp.
CSL
Daiichi Sankyo
Dainippon Sumitomo
Eisai
Eli Lilly & Co.
Forest
Gilead Sciences
GlaxoSmithKline
Grifols SA
Hospira
Johnson & Johnson
Kyowa Kirin
Lundbeck
Menarini
Merck
Merck KGaA
Mitsubishi Tanabe Pharma
Mylan
Novartis
Novo Nordisk
Ono Pharmaceutical Co.
Otsuka Pharmaceutical
Pfizer
Purdue Pharma
Reckitt Benckiser
Roche
Sanofi
Santen Pharmaceuticals
Servier
Shionogi
Shire
Taisho Pharmacueitcal
Takeda
TEVA
UCB
Valeant Pharmaceuticals
Warner Chilcott
Watson

While the report looks at the entire pipeline to 2015, a key focus of the report is the increasing role of biopharmaceutical products. The growing interest in biotechnology development has transitioned the pharmaceutical industry to biopharmaceuticals in less than a decade. Companies such as Pfizer, Merck and Novartis have been unable to ignore the benefits of investing in biotechnology and have focused on a pipeline in this direction through strategic acquisitions and partnerships with biotech companies and/or through their own in-house research efforts.

Pipeline Analysis, Key Trends, Market Forecasts



This Kalorama Information market research report captures these trends, extracting sales for all pharmaceutical and biopharmaceutical products (excluding prophylactic vaccines and OTC products) and providing estimates and forecasts of the world biopharma market.

As part of its coverage, the report provides the following:
Company Analysis
Pipeline Snapshot: Top 20 Companies
Market Trends and Value
Evaluating Changes in 2011 Market Value
The Traditional Pharmaceutical Market
Biotechnology Market Facts and Forecast

For the purpose of this study, Kalorama Information has extracted sales for human pharmaceutical and biopharmaceutical products; consumer pharmaceuticals and products; diagnostics; devices; chemicals; agriculture; and animal health. These are areas where many of these companies also compete with significant market shares.

The industry has struggled in recent years but many observers see biopharmaceutical as the key to continued success for market leaders. Biopharmaceuticals are defined as any substance produced by natural organisms or recombinant techniques consisting of proteins and other products derived from living organisms for the treatment or management of diseases or injuries. Biopharmaceuticals are created through fermentation, recombinant DNA technology, and other bioprocesses. The complex nature of biopharmaceuticals and the growing interest in development of these products has resulted in a flood of new issues affecting the already complicated healthcare market. There are a number of issues and trends which are experienced by the healthcare industry as a whole and others which are unique to biopharmaceuticals, their development and commercialization.

Issues and Trends discussed in this report include:
Biotechnology Drug Development
Orphan Drugs
Fast Track Drug Status
Other Accelerated Methods for Drug Approval
Pharmaceutical Regulatory Exclusivity
Biosimilar Development
Aging Populations
Mergers, Acquisitions, and Collaborations
Contributors to R&D Success
R&D Spending Trends
The Role of Contract Research Organizations
Sustainability in a Changing Pharmaceutical Industry

Cell Phone-Enabled Diagnostics: mHealth Applications in IVD

Mobile health has reached in vitro diagnostics and as this Kalorama report details, may change the industry forever. Over the years, the introduction of transportable, portable, and handheld instruments has resulted in the migration of clinical lab testing from the central lab to a range of environments including self-testing, community clinics, the workplace, home, disaster care and most recently, retail convenience clinics. In spite of promotional materials that emphasize ease of use, the majority of currently available POC tests require a fair amount of medical lab know-how, especially in the interpretation of the test result.

The goal is for cell phone-enabled test devices to provide primary care for underserved areas in developed countries and low income developing markets. Especially since new technologies are allowing POC devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, to a remote caregiver service for consultation or to an electronic medical record.

Get your copy of this report @ http://www.reportsnreports.com/reports/190904-cell-phone-enabled-diagnostics-mhealth-applications-in-ivd.html

Report Details:
Published: August 2012
No. of Pages: 130
Price: Single User License – US$2500 Corporate User License – US$5000

This report, Cell Phone-Enabled Diagnostics: mHealth Applications in IVD tracks cell phone-enabled products on the market and how they will affect the existing diagnostic industry. As part of this report's coverage, the following is included:

Representative Cell Phone-Enabled Products in Diabetes, Immunoassays, Hematology, Histology and Molecular IVD.
· Market Outlook for mHealth In IVD and The Best Areas For Commercial Success
· Description of the Market Leaders, Organizations and Companies In This Market.
· Government and Payer Support for mHealth
· The Role of New technologies in the Evolution of POCT
· Consumer, Physician and Payor Willingness
· How Upstarts are Faring Vs. Established Products
· Analyst Conclusions

Kalorama lead diagnostic analyst Shara Rosen, R.T., MBA presents the new developments in the convergence of IVD and mobile technologies in this unique overview of the mHealth IVD market. The company profile chapter provides a selection of companies and organizations that are pioneering the use of specially designed digital and or wireless and cell phone-enabled test devices for clinical diagnostic applications. The most advanced applications are available for glucose self-testing and the transmission of stained slide images in histology, microbiology and hematology for remote consultation with and analysis by an expert. The following companies are profiled.

· Accuster Technologies Pvt. Ltd.
· AgaMatrix, Inc.
· Alere
· ARKRAY
· ARUP Laboratories
· Axxin
· BBInternational
· BIO-key International, Inc.
· BodyTel Europe GmbH
· California Institute of Technology (Caltech)
· CellScope
· CellScope Inc.
· Clearbridge BioLoc Pte Ltd
· Columbia University
· DNAFORM
· eSTI – (Electronic self-testing instruments)
· Entra Health Systems
· Freescale Semiconductor
· Bill and Melinda Gates Foundation
· Gene-Z
· Genomic Health, Inc.
· GenPrime, Inc.
· Gentag Inc.
· GlySens Incorporated
· Harvard University Medical School
· Heidelberger-Medical-Marketing GmbH (HMM GmbH)
· HolGenTech Inc.
· Holomic LLC (formerly Microskia)
· Infopia Co Ltd
· Intelligent Optical Systems, Inc.
· Korea Advanced Institute of Science of Technology (KAIST)
· Labonfoil Consortium
· Leica Microsystems
· Lifescan Inc.
· Massachusetts General Hospital
· MAVAND Solutions GmbH
· MEDIWISS Analytic GmbH
· Medtronic Inc.
· MycroLab Pty Ltd.
· NextLab
· Oasis Diagnostics
· Oasis Scientific, Inc.
· QIAGEN N.V.
· QuantuMDx Group Limited
· Sano Intelligence
· Skannex
· TelCare Inc.
· Università Commerciale Luigi Bocconi
· University of Arizona
· University of Washington
· X out TB

The companies selected are those that are pioneers in their field and that provide an overview of the innovations underway in cell phone-enabled diagnostics. The information presented in this report is derived on publicly available information sources such as company, government, and medical organization reports. The analysis is based on the author's industry knowledge combined with literature searches and interviews with industry professionals and experts in the areas of POC tests, mobile health, decentralized healthcare and healthcare economics.

The use of cell phone-enabled diagnostics is in the earlystages of development in both developed and developing world markets. Thereforethis market analysis is somewhat speculative.In spite of the buzz about the use of cell phone-enabled test devices inmHealth, there are so many combinations of devices, applications and marketsthat the market is hard to define with precision.

Current mHealth programs that use cell phones as part of thediagnostic process (with the exception of glucose self-testing) have beeninitiated as pilot projects in developing countries with little or no concreteplans for their continuation as fully funded and government supportedhealthcare services.

Further, since much of the current mHealth products aredelivered as smartphone apps and services that are offered as part of a productoffering, it is difficult to estimate the size of the opportunity. Nevertheless, this report takes a bold lookinto the possibilities for cell phone-enabled testing in the next five to tenyears.




Explore more reports on Healthcare @ http://www.reportsnreports.com/market-research/healthcare/

Epigenomics, Present and Future Applications for Pharmaceuticals and Diagnostics

"Mabs" and molecular tests are among the growth industries of pharmaceuticals and diagnostics, but they may have competition long-term from an unexpected source. Epigenomics is a potential game-changer in the clinical therapeutics market and significant in testing as well. It refers to technologies involving changes in genetic material that find their origins in causes other than base pairs alterations in the DNA of the host. Examples of such changes include DNA methylation and histone acetylation, both of which have been known for many years to cause changes in gene expression. This report Epigenomics, Present and Future Applications for Pharmaceuticals and Diagnostics describes the progress that has been made in our understanding of the basic science of epigenomics and considers the practical accomplishments being reported by the private sector.

Epigenomics constitutes a challenge to the long held paradigm of DNA base pair sequences as the prime determinant of the phenotype. Because of this profound intellectual shift, a vast new area of biological investigation is rapidly unfolding. This presents significant opportunities for understanding disease processes and developing the means of combating them.

Get your copy of this report @ http://www.reportsnreports.com/reports/190910-epigenomics-present-and-future-applications-for-pharmaceuticals-and-diagnostics.html

Report Details:
Published: August 2012
No. of Pages: 160
Price:Single User License:US$3995            Corporate User License:US$7990



Epigenomic Mechanisms Discussed in the report include:

• DNA methylation
• Histone Acetylation
• Histone Phosphorylation
• Methylation
• Sumoylation
• Histone “chaperones”
• MicroRNAs (miRNAs)

The examination of many diseases in a completely new light means there exist a wealth of opportunities to develop new diagnostic and therapeutic approaches. At the same time it means that outdated concepts will have to be revised. This report looks at the science behind epigenomics and deals with opportunities for product development based on epigenetic technologies and the outlook for the future in this exciting area of pharmaceutical technologies. In doing so, the report provides:

• Discussion of the Basic Science and Mechanisms Behind Epigenomics
• Activities of Top Companies in the Market
• Interviews with Researchers and Private Sector Leaders
• Market Estimates for Current Epigenomic Drugs and Forecast to 2017
• Market Estimates for Current Epigenomic Diagnostics and Comparison to Next Gen Cancer Diagnostics Market
• Analyst Conclusions Regarding the Future Market for Epigenomics
• Key Healthcare Segments Impacted by Epigenomics
• Examples of Clinically Relevant Epigenetic Biomarkers
• Currently Approved Epigenomic Drugs
• Epigenetic Drivers of Disease
• Pharmaceutical R&D: A Need for Better Returns
• Look at Applications in Alzheimer’s Disease, Mental Illness, Auto-Immune Diseases, Autism and Cardiovascular Disease

The report strives to predict the potential for epigenomics while reminding market-watchers of the challenges and possible limiting factors in this market. As the report states:

"In the examination of Google hits for “Epigenomics,” the phrases “exciting”, “state of the art”, “cutting edge”, “innovative”, “breakthrough” and other clichés are encountered over and over. These terms are frequently employed to cover up ideas, concepts and scientific discoveries that may NOT be cutting edge or state of the art and may be past their time, or may never have reached their time. For this reason the report will consider which of these technologies have value and may be ripe for exploitation."

The study of epigenomics today finds itself at a tuningpoint, with many unanswered questions and a proliferation of opportunities forproducts based on the constant flow of new research findings. This report is essential for pharmaceutical and diagnostic marketers looking to develop future business plans and determine opportunities in a promising field.

Initiating Rare Disease Drug Discovery Projects

In comparison with major diseases, the targeting of rare diseases poses many different challenges, necessitating consideration of bespoke R&D strategies for successful drug discovery efforts to be successful. This report examines the issue that need to be considered in the earliest stages of embarking on a rare disease project.

Features and benefits

• Understand why rare diseases make attractive targets for launching new drug discovery projects.
• Identify the key challenges that are presented by low patient prevalences.
• Assess how the research strategy chosen can be influenced by the disease prevalence.
• Understand the importance of considering issues of similarity versus other orphan drugs.
• Compare the scenarios in which repurposing existing drugs offers advantages over the development of novel drugs, and vice versa.

Get your copy of this report @ http://www.reportsnreports.com/reports/190570-initiating-rare-disease-drug-discovery-projects.html

Report Details:
Published: August 2012
No. of Pages: 40
Price:Single User License:US$2875 Corporate User License:US$10781



Highlights
While disease prevalence has an impact on the commercial viability of a new treatment, returns are achievable even for ultra rare conditions. Rare diseases can provide sufficient opportunities for commercialization of multiple therapeutic agents. This is the case even for some ultra rare conditions such as Gaucher disease and Fabry disease.

Both clinical experts and patient groups provide valuable resources in understanding a rare disease and in identifying potential patients for clinical studies.

Many opportunities remain to develop treatments for untreated rare diseases. However, ultra rare diseases with high infant mortality present major challenges.

Your key questions answered

• Can more than one drug be a commercial success for treating rare indications?
• What are the best ways of identifying patients for recruitment into clinical trials?
• Why it is necessary to consider logistic issues in planning clinical studies?
• What are the requirements for a clinical candidate to treat a rare disease?
• What factors determine whether a small-molecule or biologic strategy is most suitable?

Organic Light Emitting Diodes - Technologies and Global Markets

This report is an update of an earlier (2011) BCC report on the global market for organic light-emitting diodes (OLEDs), the goal of which is to analyze the latest developments in this rapidly developing market. Specific objectives include quantifying the market in 2012 and analyzing its growth potential in the years through 2017, with a focus on the two major market segments for OLEDs (electronic displays and solid-state lighting), as well as emerging markets such as sensors. Additional objectives include discussing recent technological developments and patent trends and analyzing the economic, political and legal/regulatory environment within which the OLED industry will continue to develop.

INTENDED AUDIENCE

The study should be of interest to display manufacturers, component makers, original equipment manufacturers (OEMs), lighting manufacturers, construction companies, distributors and system integrators. It will also provide useful information to manufacturers of information systems, personal computers, tablet computers, televisions, lighting systems and other consumer electronic products, instrumentation, telecommunications equipment, appliances, transportation equipment, and medical devices. Finally, its contents should interest architects, builders and home designers.

SCOPE OF REPORT

The study analyzes the global market for OLED electronic displays and lighting devices through 2017, as well as the geographical breakdown of OLED production and consumption. The market for other emerging OLED applications, such as sensors, is also covered in less detail.

The study also includes the following major elements:

• Industry structure.
• Technology trends and patent analysis.
• Global economic environment.
• Government, industry and academic support.

Get your copy of this report @ http://www.reportsnreports.com/reports/120545-organic-light-emitting-diodes-oleds-technologies-and-global-markets.html

Report Details:
Published: August 2012
No. of Pages: 91
Price:Single User License:US$4850 Corporate User License:US$8500


INFORMATION SOURCES AND METHODOLOGY

Both primary and secondary research methodologies were used in preparing this study. BCC interviewed approximately 125 companies to obtain data for this study, including manufacturers of OLED displays and components, lighting devices, consumer products, communication systems, instrumentation, and transportation equipment. BCC also spoke with OLED users in a variety of industries and compiled data from current financial/trade information, such as trade publications and financial reports and government sources.

The base year for analysis and projection is 2011. With 2011 data (actual or estimated) as a baseline, market projections were developed for 2012 to 2017. These projections are based on a combination of a consensus among the primary contacts combined with BCC’s understanding of the key market drivers and their impact from a historical and analytical perspective.

The methodologies and assumptions used to develop the market projections in this report are discussed at length in the detailed market estimates and projections for each OLED application. The report carefully documents data sources and assumptions. This way, readers can see how the market estimates were developed and, if they so desire, test the impact on the final numbers of changing assumptions such as price.

ANALYST CREDENTIALS

The original report on which this updated edition is based was prepared by Bob Moran. Mr. Moran has worked as a technology market analyst and technology writer for more than 20 years and is the author of numerous BCC Research reports. He has authored reports covering thin film deposition, photovoltaic solar technology, electronic gaming, magnetic and optical storage, surface modification of polymers, and other technology topics. He has also served as the editor of BCC Research publications, including Display Industry News and Micro and Nanotechnology.

The analyst responsible for updating the report is Andrew McWilliams, a partner in the Boston–based international technology and marketing consulting firm, 43rd Parallel LLC. Mr. McWilliams is the author or co-author of many other BCC studies, including studies in related fields such as NAN031D Nanotechnology: A Realistic Market Assessment; NAN036B Nanotechnology for Photonics: Global Markets; AVM078A New Electronic Materials and Device Technologies: Global Markets; and SMC018D Light-Emitting Diodes (LEDs) for Lighting Applications.

2012 Deep Research Report on Global and China Aramid Fiber Industry

2012 Deep Research Report on Global and China Aramid Fiber Industry was a professional and depth research report on Global and China Aramid Fiber Industry. Firstly the report describes the background knowledge of Aramid Fiber, including Concepts Classification production process technical parameters; then statistics Global and China 16 Aramid Fiber Manufacturers (Aramid 1414 and Aramid 1313) Aramid Fiber product Capacity production cost price production value profit margins and other relevant data, statistics these enterprises Aramid Fiber products, customers, raw materials, company background information, then summary statistics and analysis the relevant data on these enterprises. We got Global and China Aramid Fiber companies production market share, Global and China Aramid Fiber demand supply and shortage, Global and China Aramid Fiber 2009-2013 production price cost Gross production value gross margins, etc. At the same time, we analyzed and discussed supply and demand changes in Aramid Fiber market and business development strategies, conduct a comprehensive analysis on Global and China Aramid Fiber industry trends. Finally, the report also introduced 3000Ton/Year Meta-aramid (Aramid 1313) project Feasibility analysis and related research conclusions. In a word, It was a depth research report on Global and China Aramid Fiber industry. And thanks to the support and assistance from Aramid Fiber industry chain related experts and enterprises during Research team survey and interview.

Get your copy of this report @ http://www.reportsnreports.com/reports/190564-2012-deep-research-report-on-global-and-china-aramid-fiber-industry.html

Report Details:
Published: August 2012
No. of Pages: 163
Price:Single User License:US$2200         Corporate User License:US$4200 



Table of Contents

Chapter One Aramid Fiber Industry Overview 1
1.1 Definition 1
1.2 Aramid Characteristic 2
1.3 Classification and Application 3
1.3.1 Aramid Classification 3
1.3.2 Aramid Application 5
1.4 Industry Chain Structure 9
1.5 Market Status and Development Trend 9
1.5.1 Aramid Industry Competition Pattern 9
1.5.2 Aramid Products Operating Comparison 10
1.5.3 Aramid Fiber International Development Status 11
1.5.4 Aramid Fiber China Development Status 12
1.5.5 Aramid Fiber Development Analysis 13
1.5.6 Aramid FiberMarket and Development Prospect 14
1.6 Policy Analysis 15

Chapter Two Aramid Fiber Product Specification and Manufacturing Process 88
2.1 Aramid Fiber Product Specification 88
2.2 Manufacturing Process 89
2.2.1 Para-aramid (1414) Manufacturing Process 89
2.2.2 Meta-aramid (1313) Manufacturing Process 90
2.3 Manufacturing Cost Analysis 91
2.4 Manufacturing Equipments List 92
2.5 Technical Trend and Difficulties 92

Chapter Three Aramid Fiber Production Supply Sales Demand Market Status and Forecast 95
3.1 Global Capacity Production Overview 95
3.2 China Capacity Production Overview 106
3.3 2009-2013 Unites States Japan Korea China etc Regional Aramid Fiber Production Overview 117
3.4 2009-2013 Global and China Para-Aramid Fiber (Aramid1414) Meta-Aramid Fiber (Aramid1313) Production and Market Share 121
3.5 2009-2013 Global and China Aramid Fiber Yarn Staple Pulp Production 123
3.6 2012 Global Aramid Fiber Capacity Utilization Rate 125
3.7 2009-2013 Aramid Fiber China Capacity Production and Proportion in Global 127
3.8 Global and China Aramid Fiber Demand Overview 129
3.9 Global and China Aramid Fiber Supply Demand Shortage 130
3.10 Global and China Aramid Fiber Cost Price Production Value Gross Margin 131
3.11 China Aramid Fiber Import Export Consumption 133

Chapter Four Aramid Fiber Key Manufacturers 135
4.1 Dupont (United States) 135
4.2 Teijin (Japan) 143
4.3 JSC «Kamenskvolokno» (Russia) 147
4.4 Kolon Industries (Korea) 152
4.5 Hyosung Corp (Korea) 156
4.6 Huvis (Korea) 159
4.7 Yantai Tayho Advanced Materials 162
4.8 Bluestar 168
4.9 China Pingmei Shenma Group 171
4.10 Sinopec Yizheng Chemical Fibre Co.,Ltd 174
4.11 Guangdong Charming 177
4.12 Hebei Silicon Valley Chemical Co.,Ltd 183
4.13 Jiangsu Zhaoda Specially Fiber 186
4.14 Shanghai Aimaida Chemical Fiber Science and Technology Co.,Ltd 189
4.15 SRO Group (China) Limited 190
4.16 Huian Group 194

Chapter Five 3000 Ton/Year Meta-aramid (Aramid 1313) Project Feasibility Analysis 196
5.1 Opportunity and Risk Analysis 196
5.2 Project Feasibility Analysis 196

Chapter Six Global and China Aramid Fiber Research Conclusions 199

Most-Needed Chemicals for New Disruptive Electronics and Electrics

The chemistry of the new electronics and electrics is key to its future, whether it is invisible, tightly rollable, biodegradable, edible, employing the memristor logic of the human brain or possessing any other previously- impossible capability in a manufactured device. De-risking that material development is vital yet the information on which to base that has been unavailable. No more.

See how the metals aluminium, copper and silver are widely deployed, sometimes in mildly alloyed, nano, precursor, ink or other form. Understand the 12 basic compounds most widely used in the new electronics and electrics and compare them with compounds exhibiting the broadest range of appropriate electrical and optical functions for the future. Those seeking low volume, premium priced opportunities can learn of other broad opportunities. Indeed, we cover in detail all the key inorganic and organic compounds and carbon isomers. We show how the element silicon has a new and very different place beyond the silicon chip. Learn how the tailoring of a chosen, widely-applicable chemical can permit premium pricing and barriers to entry based on strong new intellectual property. For example, see which of 15 basic formulations are used in the anode or cathode of the re-invented lithium-ion batteries of 131 manufacturers and what comes next.

Get your copy of this report @ http://www.reportsnreports.com/reports/190566-most-needed-chemicals-for-new-disruptive-electronics-and-electrics.html

Report Details:
Published: September 2012
No. of Pages: 176
Price:US$4995         

We identify 37 families of new and rapidly-evolving electronic and electric device, spanning nano to very large devices. Most chemical and material companies wish to de-risk their investment by finding common formulations across this new business that has a potential of over $50 billion for them. This will reduce R&D cost and provide escape routes to sell their current formulations elsewhere if they prove unsuccessful in the first application addressed. Indeed, the biggest markets for new and reinvented electrical and electronic devices may get commoditised first or collapse suddenly, leaving the materials suppliers high and dry. Read this report to avoid such a fate.

Who should buy this report?
All advanced chemical and material manufacturers and developers - both chemical companies and equipment manufacturers with deep vertical integration like Toyota, Hewlett Packard and Intel.

To a lesser extent those making the devices and key circuit technologies such as printed electronics, organic electronics, wide area electrics and very high volume electronics. Smart packaging. Smart labels. Investors and acquirors in these industries, particularly in advanced chemical and material manufacturers and developers. Academics and research centers covering advanced chemicals and materials for electronics and electrics. Particularly huge opportunity in Japan, Germany and USA.

Deep Offshore Oil and Gas Exploration and Production in West Africa - Market Analysis, Competitive Landscape and Forecasts to 2020

This new report “Deep Offshore Oil & Gas Exploration and Production (E&P) in West Africa - Market Analysis, Competitive Landscape and Forecasts to 2020” provides an overview of the deep offshore E&P in West Africa. The report provides information on the major deep offshore oil and gas projects and key companies in Nigeria, Angola, Equatorial Guinea, the Republic of Congo and Ghana. The report is compiled by using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Buy your copy of this report @ http://www.reportsnreports.com/reports/190565-deep-offshore-oil-gas-exploration-and-production-ep-in-west-africa-market-analysis-competitive-landscape-and-forecasts-to-2020.html
Report Details:
Published: September 2012
Price:Single User license:US$3995 Corporate User License:US$ 11985



Scope

• Drivers and challenges for E&P in deep offshore West Africa.
• The contribution from the countries in the region to West Africa's offshore oil and gas production.
• Key companies in the E&P industry of deep offshore West Africa.
• The E&P fiscal environment in Nigeria, Angola, Equatorial Guinea, the Republic of Congo and Ghana.
• The competitive landscape of the companies engaged in E&P activities in Nigeria, Angola, Equatorial Guinea, the Republic of Congo and Ghana.

Reasons To Buy

• Gain insight on the deep offshore West African market.
• Understand key drivers and challenges of the deep offshore West African market.
• Learn about deep offshore oil and gas E&P in Nigeria, Angola, Equatorial Guinea, Republic of the Congo, and Ghana.
• To be informed about the operations of key companies engaged in deep offshore E&P of oil and gas in the West Africa region

Methodology
GlobalData's dedicated research and analysis teams consist of experienced professionals with marketing, market research and consulting backgrounds in the energy industry, and advanced statistical expertise. GlobalData adheres to the codes of practice of the Market Research Society and the Strategic and Competitive Intelligence Professionals.

Future Horizons in the Global Enteric Disease Market

This report presents detailed analysis of the Enteric Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are presented for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The report provides test volume and sales forecasts by country and market segment, including: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health LabsIn addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of enteric disease diagnostic products, by test and country. Also, the report: - Examines market applications of Molecular Diagnostics,Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; - Reviews features and operating characteristics of major analyzers used for enteric disease testing; - Profiles key suppliers and potential market entrants developing innovativetechnologies and products; and - Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.MethodologyThe report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan. In addition to primary sources of information, a comprehensive review ofthe most recent technical and business publications, manufacturer productand financial literature, as well as Venture Planning Group’s proprietary data files was conducted.

Get your copy of this report @ http://www.reportsnreports.com/reports/190562-future-horizons-in-the-global-enteric-disease-market.html

Report Details:
Published: August 2012
No. of Pages: 389
Price:Single User license:US$9800           Corporate User License:US$21500



Table Of Contents

Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. Campylobacter
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Cryptosporidium
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. E. Coli
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Enteroviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. RhinoViruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. RotaVirus (REOVIRUS)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
7. Salmonellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Shigellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. Vibrio
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. Yersinia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other

III. France: Market Size, Growth and Major Suppliers’ Sales and Market Shares

IV. Germany: Market Size, Growth and Major Suppliers’ Sales and Market Shares

V. Italy: Market Size, Growth and Major Suppliers’ Sales and Market Shares

VI. Japan: Market Size, Growth and Major Suppliers’ Sales and Market Shares

VII. Spain: Market Size, Growth and Major Suppliers’ Sales and Market Shares

VIII. UK: Market Size, Growth and Major Suppliers’ Sales and Market Shares

IX. USA: Market Size, Growth and Major Suppliers’ Sales and Market Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges Competitive Assessments

Application Server: Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018

WinterGreen Research announces that it has published a new study Mission Critical J2EE Application Server: Market Shares, Strategy, and Forecasts, Worldwide, 2012 to 2018. The 2012 study has 686 pages, 297 tables and figures. Worldwide Application Server markets are poised to achieve significant growth as Internet of things and the mobile Internet further evolve.

According to Susan Eustis, lead author of the study, “Significant investment in communications infrastructure will create demand for more sophisticated web development and web applications. Everything is going mobile. This evolution is driven by mobile smart phones and tablets that provide universal connectivity. Application servers represent a significant aspect of Internet market evolution.”

Application server mobile extensions are integrated in the Web apps development environments of vendors. Application server development can create Web applications using business server pages. They can use the mobile extensions of the Web application server, which makes the special requirements and characteristics of mobile devices available.

Application servers leverage evolving software delivery models, new development methodologies, emerging mobile application development, and open source software. Mobile application development projects targeting smartphones and tablets are an essential aspect of any departmental application initiative. Native PC projects are anticipated to give way to smartphone and tablet apps for the enterprise. Every enterprise has to have apps that give customers, distributors, partners, and suppliers access to information.

Buy your copy of this report @ http://www.reportsnreports.com/reports/190567-application-server-market-shares-strategies-and-forecasts-worldwide-2012-to-2018.html

Report Details:
Published: August 2012
No. of Pages: 686
Price:Single User License:US$3700 Corporate User License:US$7400



The smarter planet initiative elucidates the value of machine to machine transmission. Ubiquitous computing environments a microprocessor touches everything, information systems, agriculture, transportation, and hospitals. Things no one would recognize as computers have a processor: home appliances, cars, roads, clothes, even rivers and cornfields. Electronic shopping, electronic trading, Internet banking, Internet brokers, music and video delivery, Internet auction and other systems have become widespread and taken for granted in the society, all leveraging computing components many of which feed information to application servers.

IBM is the dominant player in application server market, it sets a defacto industry standard for complex web offerings. IBM has achieved significant market advantage by positioning with a broad middleware product offering. IBM has been able to grow its market share steadily. The IBM WebSphere has robust functionality. It provides integration at every level of the IT systems.

IBM is able to leverage application servers, broker integration technology, business process management, mission critical messaging, and portals with a broad offering. Built in intelligence frequently leverages application servers that are used to create a web presence and manage the flow of information from sensors to systems.

Application servers are used to manage e-commerce and service interactions over the Web. Application servers support continuous, personalized web presence. The application server web capability represents expansion of earlier web based systems. New systems are more integrated. Systems vastly improve the reach of e-commerce sites. Analytics have been added. The aim of e-commerce is to achieve an expanding customer base, enhance customer retention, improve customer service, and achieve cross selling.

Manufacturers use application servers to improve the functioning of the supply chain. Service interactions are supported over the Web. Systems facilitate product design, inventory management, distribution, and shipment processes.

Application servers represent the core of cloud and the Web computing technologies. Efficient real time systems are critical to responding to demands imposed by implementing business process that is automated. The application server requirements are described below. Application server core technologies are failover, clustering, scalability, flexibility, and reliability.

Mission critical application servers implement web based applications to improve cloud and globally integrated enterprise applications.

Mobile changes how consumers behave. Users leverage mobility to communicate. They use it to improve their daily lives. Mobile is growing through existing data services and new services. Users demand connectivity anywhere and anytime. Enterprises are beginning to exploit the opportunities provided by mobility. Mobile communications permit the enterprise improve efficiency by enabling remote services and sales people to work efficiently, by enabling better access to enterprise records from remote sites, by streamlining processes, and by supporting new business models.

Worldwide application server market revenues are forecast to grow 17% year-over-year from $7 billion in 2011 to $21.2 billion by 2018. This is in the context of a world communications infrastructure that is changing. Technology is enabling interaction, innovation, and sharing of knowledge in new ways and application servers promise to bring significant capability to enterprises seeking mission critical solutions to making the Internet available for productive, efficient use.